Swiss National Bank - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$192,000
+14.3%
58,2000.0%0.00%
Q2 2016$168,000
-53.1%
58,200
+9.2%
0.00%
-100.0%
Q1 2016$358,000
-6.8%
53,300
+21.1%
0.00%0.0%
Q4 2015$384,000
+33.3%
44,0000.0%0.00%0.0%
Q3 2015$288,000
-32.6%
44,000
+12.8%
0.00%0.0%
Q2 2015$427,00039,0000.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Abingworth LLP 327,350$2,943,0001.62%
HealthCor Management, L.P. 1,575,000$14,207,0000.86%
Cormorant Asset Management, LP 200,000$1,804,0000.42%
BVF INC/IL 184,999$1,669,0000.26%
Verity Asset Management, Inc. 28,410$244,0000.25%
Callan Capital, LLC 80,478$726,0000.24%
MARXE AUSTIN W & GREENHOUSE DAVID M 225,000$2,029,0000.22%
EMERALD MUTUAL FUND ADVISERS TRUST 61,846$558,0000.05%
LMR Partners LLP 11,815$106,0000.02%
Weiss Multi-Strategy Advisers LLC 70,000$631,0000.01%
View complete list of REGULUS THERAPEUTICS INC shareholders